Buchbinder A - Search Results

1

Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen.

Bayer RL, Lichtman SM, Allen SL, Budman DR, Buchbinder A, Fetten J, Kolitz J, Loscalzo J. Bayer RL, et al. Among authors: buchbinder a. Am J Hematol. 1999 Jan;60(1):70-1. doi: 10.1002/(sici)1096-8652(199901)60:1<70::aid-ajh12>3.0.co;2-d. Am J Hematol. 1999. PMID: 9883809 Free article.

2

Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies.

Lichtman SM, Attivissimo L, Goldman IS, Schuster MW, Buchbinder A. Lichtman SM, et al. Among authors: buchbinder a. Am J Hematol. 1999 Aug;61(4):262-4. doi: 10.1002/(sici)1096-8652(199908)61:4<262::aid-ajh7>3.0.co;2-b. Am J Hematol. 1999. PMID: 10440913 Free article.

3

Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.

Serrano D, Monteiro J, Allen SL, Kolitz J, Schulman P, Lichtman SM, Buchbinder A, Vinciguerra VP, Chiorazzi N, Gregersen PK. Serrano D, et al. Among authors: buchbinder a. J Immunol. 1997 Feb 1;158(3):1482-9. J Immunol. 1997. PMID: 9013995

4

A phase I study of sequential vinorelbine followed by paclitaxel.

Budman DR, Weiselberg L, O'Mara V, Buchbinder A, Lichtman SM, Donahue L, Adams LM. Budman DR, et al. Among authors: buchbinder a. Ann Oncol. 1999 Jul;10(7):861-3. doi: 10.1023/a:1008351915582. Ann Oncol. 1999. PMID: 10470436 Free article. Clinical Trial.

5

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Damle RN, et al. Among authors: buchbinder a. Blood. 1999 Sep 15;94(6):1840-7. Blood. 1999. PMID: 10477712 Free article.

6

Rearrangement and expression of MDM2 oncogene in chronic lymphocytic leukemia.

Huang YQ, Raphael B, Buchbinder A, Li JJ, Zhang WG, Friedman-Kien AE. Huang YQ, et al. Among authors: buchbinder a. Am J Hematol. 1994 Oct;47(2):139-41. doi: 10.1002/ajh.2830470215. Am J Hematol. 1994. PMID: 8092130

7

Gene therapy in human cancer: report of human clinical trials.

Wasil T, Buchbinder A. Wasil T, et al. Among authors: buchbinder a. Cancer Invest. 2000;18(8):740-6. doi: 10.3109/07357900009012206. Cancer Invest. 2000. PMID: 11107444 Review. No abstract available.

8

Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.

Gorny MK, Xu JY, Karwowska S, Buchbinder A, Zolla-Pazner S. Gorny MK, et al. Among authors: buchbinder a. J Immunol. 1993 Jan 15;150(2):635-43. J Immunol. 1993. PMID: 7678279

9

The absence of Tat sequences in tissues of HIV-negative patients with epidemic Kaposi's sarcoma.

Huang YQ, Buchbinder A, Li JJ, Nicolaides A, Zhang WG, Friedman-Kien AE. Huang YQ, et al. Among authors: buchbinder a. AIDS. 1992 Oct;6(10):1139-42. doi: 10.1097/00002030-199210000-00012. AIDS. 1992. PMID: 1466845

10

Clinical aspects of epidemic Kaposi's sarcoma.

Buchbinder A, Friedman-Kien AE. Buchbinder A, et al. Cancer Surv. 1991;10:39-52. Cancer Surv. 1991. PMID: 1821322 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters